Journal of Pharmacology & Pharmaceutical Research

Journal of Pharmacology & Pharmaceutical Research

Journal of Pharmacology and pharmaceutical research (JPPR), is an International, online journal to expedite rapid publication and to introduce unique innovations and discoveries in pharmacy medicine. JPPR publishes full length research reports, review articles, and scientific commentaries & communication on all aspects of the pharmaceutical sciences with strong emphasis on novelty, originality and scientific quality. The journal essences on advancing therapeutic sciences produced from basic sciences, clinical, and research group or general well-being exploration to coordinate looks into in all parts of human well-being. The aim of the journal is to provide a platform globally for pharmacologists, academicians, researchers, scholars and scientists emphasizing Pharmaceutical research.

The scope of the journal includes Pharmaceutical Technology, Pharmaceutical Chemistry, Pharmaceutics, Pharmacy Practice, Pharmacognosy, Pharmacology, Physical Pharmacy, Pharmacogenomics, Pharmacoinformatics , Pharmaceutical and Biomedical Analysis, Pharmacovigilance , Formulation Technology, Novel Drug Delivery, Industrial Pharmacy, Stability of Drugs, Therapeutic Drug Monitoring Quality Assurance, Vaccines, Intellectual Property Right, Pharmaceutical Biotechnology and Microbiology, Clinical Drug Evaluation, Toxicity Studies, Biopharmaceutics, Natural Product Research, Computational Chemistry and Molecular Drug Design, Clinical trials, Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Protein – Peptide Chemistry, Bioinformatics, Drug Targeting, Drug Absorption & Metabolism, Drug Regulatory Affairs, Product Development, Molecular Pharmacology, Drug Side Effect, Drug Discovery & Design, Drug Delivery, Adverse Drug Reactions, Action of Drugs, Marine Pharmacognosy, and Nutraceuticals.

You are welcome to submit your work to submissions@researchopenworld.com

Open Access Policy: This journal is an open access journal which provides immediate, worldwide, boundary free access to the full content of every distributed article without charging readers or their institutions for access. Readers are given authorization to read, circulate, copy, print, download, search, or link to the full texts of all articles in JPPR.

Editorial Board

Editor In Chief

Dr. Sinerik Ayrapetyan
Head of Research and Educational Council,
Head of UNESCO Chair in Life Sciences,
Life Sciences International Postgraduate Educational Center (LSIPEC),
Yerevan, Armenia

Prof. Niels Juel Christensen

Department of Biomedical Sciences,
Faculty of Health Sciences,
University of Copenhagen,
Denmark


Dr. Raffaele Capasso

Department of Experimental Pharmacology,
University of Naples Federico II,
Naples,
Italy


Prof. Emilio Bucio-Carrillo

Department of Radiation Chemistry,
National University of Mexico,
Mexico


Prof. Fathi Mohamed Omer Sherif

Department of Pharmacology & Clinical Pharmacy,
Faculty of Pharmacy,
University of Tripoli,
Libya


Dr. Mohamad Abadelah

Department of Pharmaceutics,
University of Huddersfield,
UK


Prof. Rania Elkeeb

Department of Pharmaceutical and Biomedical Sciences,
Northstate University College of Pharmacy,
California,
USA


Prof. Jose Ricardo

Department of Periodontics,
Sao Paulo State University,
Brazil

Prof. Loutfy H. Madkour

Department of Chemistry,
Faculty of Science and Arts,
Al Baha University, Baljurashi,
Saudi Arabia


Prof. Diego Liberati

Research Director,
Information, Control & Biomedical Engineering,
National Research Council of Italy,
Italy


Prof. Chung-Yi Chen

School of Medical and Health Sciences,
Fooyin University, Kaohsiung,
Taiwan


Prof. Linh Ho

Department of Pharmaceutical and Biomedical Sciences, California Northstate University College of Pharmacy, California,
USA


Dr. Bill W Massey

Chief of science Officer,
Opiate treatment centers of America,
Texas, USA


Prof. Chandra Kolli

Department of Pharmaceutical and Biomedical Sciences,
California Health Sciences University,
California,
USA


Prof.Thierry Vandamme

Faculty of Pharmacy,
University of Strasbourg,
Strasbourg,
France


Prof. Patrícia Mazureki Campos

School of Pharmaceutical Sciences of Ribeirão Preto,
State University of Ponta Grossa, Parana,
Brazil


Dr. Sidharth Mehan

Department of Pharmacology,
ISF College of Pharmacy,
India


Prof. Huyen Vu

Department of Clinical and Administrative Sciences,
Northstate University College of Pharmacy,
California,
USA


Prof. Rafik Karaman

College of Pharmacy,
Al-Quds University, Jerusalem,
Palestine


Dr. Bogdan Socea MD, PhD

General Surgery Department,
“Sf. Pantelimon” Emergency Clinic Hospital,
Carol Davila University of Medicine and Pharmacy,
Bucharest,
Romania


Published Articles

Cruzain Inhibitors as Prominent Molecules with The Potential to become Drug Candidates against Chagas Disease

Leonor Yamile Vargas-Méndez and Vladimir V. Kouznetsov

Research Article – J Pharmacol Pharm Res

Saying NO to Drugs: Two Mind Sets & Messaging Direction

Stephen Onufrey, Attila Gere, Janna Kaminskaia, Martin Braun, Petraq Papajorgji, Marilyn Hudson and Howard Moskowitz

Review Article – J Pharmacol Pharm Res

Oral Drug Compounding in Pediatric Patients: a Japanese Perspective

Jumpei Saito, Miki Akabane, Hidefumi Nakamura, Yoichi Ishikawa and Akimasa Yamatani

Commentary – J Pharmacol Pharm Res

Comparison of Various Selection Strategies Used for Isolation of Human Monoclonal scFv Antibody Specific to GPCRs Heteromers

Sylwia Łukasiewicz, Agata Stachowicz, Monika Bzowska and Marta Dziedzicka-Wasylewska

Research Article – J Pharmacol Pharm Res

Can One-Stage In Vitro Dissolution Using Water As Medium Represent Guaifenesin Release From Extended- Release Bilayer Tablets?

Monica C. Chuong, Pamela Navarro Gonzales, Lei He, Reina Kitagawa, Mitchell N. Lobo, Bhagyashree V. Salvi, Aishwarya L. Saraswat and Pornpawit Suriyamongkol

Short Commentary – J Pharmacol Pharm Res

Action of an Indolinone Derivative on Plasma Hemostasis

Bykov VV, Serebrov VYu, Udut EV and Udut VV

Research Article – J Pharmacol Pharm Res

Reimbursement Challenges in Europe for Innovative Therapies

Jenifer Ehreth

Short Commentary – J Pharmacol Pharm Res

Ensure Quality Assurance for Companies and Institutions

Dr. Boyd L. Summers

Short Commentary – J Pharmacol Pharm Res

Effective Processes for Quality Assurance

Dr. Boyd L. Summers

Short Commentary – J Pharmacol Pharm Res

JAK Inhibitors: New Treatments for RA and beyond

Peter G. Ruminski and John F. DiPersio

Opinion – J Pharmacol Pharm Res

Mithramycin-A Induced Toxicity in HepG2 Cells is mediated by Disruption of Calcium Homeostasis

Emad Darvishi, Jacob Benjamin Lissoos, Cheryl Lynn Thomas and Girma Moges Woldemichae

Research Article – J Pharmacol Pharm Res

Studies on the Evaluation of Preservative Efficacy of 2-Pyrrolidone for Oral Paediatric Formulations

Smola M, Muller G, Sizarols J, Zhao M, André Ph, Vandamme Th F

Research Article – J Pharmacol Pharm Res

Pattern of Anti-Epileptic Drug use in Libyan Children and Their Effects on Liver Enzyme Activities

Mudafara S Bengleil, Fathi M. Sherif

Research Article – J Pharmacol Pharm Res

DOI: 10.31038/JPPR.1000104

Drug discovery: science and/or art?

Diego Liberati

Editorial – J Pharmacol Pharm Res

DOI: 10.31038/JPPR.1000102

Pharmacokinetics of Acetaminophen in the Hypothalamus of Rats Based on in vivo Microdialysis

Yue Zhu, Zhang-Qing Ma, Shou-Yun He, Ya-Lan Wang, Zong-Yuan Hong

Research Article – J Pharmacol Pharm Res

DOI: 10.31038/JPPR.1000101

Submit Manuscript

Please submit your manuscript to submissions@researchopenworld.com

Indexing

JCRM journal has received impact factor of 1.02 for its 2018 volume.